Puzzling Over the Hurt Down-Under
Serious Mental Illness and Contraception
New 13-Cycle Vaginal Contraceptive System
The Future of Family Planning in Post-COVID America
New ASCCP Guidelines: Implications for FP
On the alert: mood disorders during 2020 stressors
Challenges old and new during the pandemic
Reproductive health in the time of Covid-19
Missed Pills: The Problem That Hasn’t Gone Away
Find the “yes! . . . and” rather than “no” or “but”
Digital Family Planning: the Future is Now
Irregular Bleeding Due to Contraceptives
Ouch! Best approaches to menstrual pain
Contraceptive efficacy: understanding how user and method characteristics play their part
Strategizing treatment for chronic heavy menstrual bleeding
Untangling the literature on obesity and contraception
High tech apps for no-tech FABM
Menstrual exacerbation of other medical conditions
From Princeton University: Thomas James Trussell (1949-2018)
The Short and Long of IUD Use Duration
Selecting a Method When Guidance Isn’t Clear-cut
Healthcare in the Time of Digital Expansion
The Scoop on Two New FDA-Approved Contraceptive Methods
Pregnancy of unknown location—meeting the challenge
Big “yes” (with caveats) to CHCs during perimenopause
The role of IUDs (LNG IUDs, too!) in emergency contraception
Combined pills’ effect on mood disorders
Abortion in the U.S.: safe, declining, and under threat
Hope for ovarian cancer screening test
Breast cancer still a small risk with some hormonal contraceptives
Record rate of HPV-related throat cancer
Viruses in semen potentially transmissible
Don’t Abstain from Your Role in Abstinence
Teens births declining but geographic ‘hotspots’ defy trend
Online Medical Abortion Service Effective and Safe
Do Women Really Need to Wait That Long?
Reassuring news on depression and OC use
PMDD: Genetic clues may lead to improved treatment
Breast cancer risk when there is a family history
Body weight link to breast and endometrial cancers (and 11 others)
Family Planning in 2017 and Beyond
Make Me Cry: Depression Link (Again)?
Managing implant users’ bleeding and spotting
Zika: Updated guidance for providers
Pharmacist-prescribed contraceptives
Hot off the press! 2016 MEC and SPR
Zika virus fears prompt increased request for abortion in nations outlawing abortions
Opioid use epidemic among reproductive-age women
Good news on the family planning home front!
War Against Planned Parenthood Hurts Women
Win-win for both treatment and prevention
Menopause, mood, mental acuity, and hormone therapy
Emergency contraception for teens
Postpartum Contraception: Now, Not Later
Are we practicing what we preach?
Be alert to VTE in hormonal contraceptive users
LARC among teens increased 15-fold, but not enough
Brain cancer and hormonal contraception
Free tools: Easy access to the US Medical Eligibility Criteria for Contraceptive Use
Alcohol consumption when pregnancy is unwanted or unintended
Latest Data on Contraceptive Use in the United States
LateBreaker sampler from Contraceptive Technology conference
Emergency Contraceptive Pill Efficacy and BMI/Body Weight
Handout on Unintended Pregnancy and Contraceptive Choice
Ask About Withdrawal (Really!)
Rules to Practice By: Safety First and Cleanliness is Close to. . .
What’s Vanity Fair Got Against the NuvaRing?
Promising New Treatment for Hepatitis C
Numbers matter, so make them simple for patients
The Recession’s Effect on Unintended Pregnancies
Lessons Learned from the Contraceptive CHOICE Project: The Hull LARC Initiative
Applying the “New” Cervical Cytology Guidelines in Your Practice
Acute Excessive Uterine Bleeding: New Management Strategies
Medical indications for IUD use in teens

Women who have acquired medical abortion pills through an online telemedicine service report successful abortions with low rates of adverse effects. Our study examined outcomes of a large sample of women in Ireland and Northern Ireland who used this service, which offers telemedicine consultation with a physician and, if indicated and appropriate, prescription and postal delivery of the abortion medication. The findings have potentially far-reaching implications.
We examined self-reported outcomes following medical abortions conducted through Women on Web (WoW), a nonprofit digital community that provides online access to medications used to induce abortion. The population-based analysis of 1,000 women in the Republic of Ireland and Northern Ireland who self-sourced medical abortion during a 3-year period examined self-reported outcomes and complications and assessed women’s ability to self-screen for the symptoms of potentially serious complications and their likelihood of seeking medical attention if complications do arise.
Almost 95% of respondents reported that they successfully ended their pregnancy without the need for surgical intervention. Seven women (0.7%) reported receiving a blood transfusion, and 26 (2.6%) reported receiving antibiotics (route of administration [IV or oral] could not be determined). No deaths resulting from the intervention were reported by family, friends, the authorities, or the media. Ninety-three women (9.3%) reported experiencing any symptom for which they were advised to seek medical attention and, of these, 87 (95%) sought attention. None of the 5 women who did not seek medical attention reported experiencing an adverse outcome.
We acknowledge the limitations of self-reporting, but we also emphasize that in situations where women self-source their own abortions outside the formal healthcare setting, self-report is the only possible method of follow-up. The strengths of the study include the large sample size and high follow-up rate, which are comparable with or, in some cases, better than studies of abortion within the formal healthcare setting.
Abortion laws in Ireland and Northern Ireland are among the most restrictive in the world, with abortion criminalized in most circumstances. However, online telemedicine has dramatically changed abortion access. Irish and Northern Irish people who access or help others to access this pathway are choosing an option that has similar effectiveness rates to medication abortion performed in a clinic and has lower rates of complications than continuing a pregnancy to delivery. Our study shows that medication abortion self-sourced and self-managed outside the formal healthcare setting can be a safe and effective option for those who rely on or prefer it.
The findings also have implications for other parts of the world where abortion is difficult to access. Women in Ireland and Northern Ireland have three options when faced with a pregnancy they do not want or feel they cannot continue: travel long distances to access in-clinic abortion care, remain pregnant, or self-source their own abortion outside the formal healthcare setting. Safe, supported, and effective at-home medication abortion could be an option for women facing similar or more severe restrictions in other nations. In the United States, following waves of restrictive legislation, state laws have forced clinics to close throughout the South, Appalachia, and the Mid-West regions. For these U.S. women, the parallels with our Irish study subjects appear striking.
The full study published in the BMJ with coauthors Irena Digol and Rebecca Gomperts is Open Access and available at no cost: http://www.bmj.com/content/357/bmj.j2011 .
—Abigail R.A. Aiken, LBJ School of Public Affairs, University of Texas at Austin and James Trussell, Office of Population Research, Princeton University